Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. Zusätzlich bieten wir Ihnen LGALS7 Antikörper (104) und LGALS7 Kits (47) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 14 products:
Increased O-linked N-Acetyl-glucosamine (O-GlcNAc) is responsible for reduced Gal-7 expression in cultured human keratinocytes exposed to high glucose environment.
We observed a significantly reduced overall survival for cases with high Gal-7 expression and a better survival for Gal-7 negative cases, when compared to cases with low expression of Gal-7.
Data suggest that evaluation of galectin-7 could help guide postsurgical management for non-metastatic clear cell renal cell carcinoma (zeige MOK Proteine) (ccRCC).
these findings reveal the existence of a positive self-amplification pathway that regulates intracellular gal-7 expression in breast and ovarian cancer cells.
Gal-7 re-expression affects the regulation of molecular networks in cervical cancer that are involved in diverse cancer hallmarks, such as metabolism, growth control, invasion and evasion of apoptosis
It is a beta-galactose-binding animal lectin and known to be distributed throughout the body.
Data indicate that the galectin inhibitor specifically binds galectin-7 (hGal (zeige GCET2 Proteine)-7), disrupts the formation of homodimers, and inhibits the pro-apoptotic activity of hGal (zeige GCET2 Proteine)-7 on Jurkat T cells.
Galectin-7 regulates keratinocytes proliferation and differentiation through JNK1 (zeige MAPK8 Proteine) pathway.
The assessment of a carbohydrate-recognition domain (CRD (zeige CRX Proteine))-defective mutant form of gal-7 (R7S) showed that the ability of this protein to modulate apoptosis was independent of its CRD (zeige CRX Proteine) activity.
our study validates the clinical significance of gal-7 overexpression in ovarian cancer
Diabetic mice model shows that increased O-linked N-Acetyl-glucosamine (O-GlcNAc) is responsible for reduced Gal-7 expression in keratinocytes exposed to high glucose environment.
The data suggest that gal-7 could potentiate the phenotype of HER-2 (zeige ERBB2 Proteine) positive primary breast cancer.
results indicate that an excess of galectin-7 leads to a destabilisation of adherens junctions associated with defects in epidermal repair
Overexpression of galectin-7 increased the resistance of melanoma cells to apoptosis while inducing de novo egr-1 (zeige EGR1 Proteine) expression.
In cardiac transplantation galectin-7 relates to acute allograft rejection and T-cell responses possibly as an accelerant.
Extracellular superoxide dismutase (zeige SOD3 Proteine) plays a role not only as a reactive oxygen species scavenger, but also as a pro-apoptotic factor via COX-2/galectin-7 pathways in the epidermis.
Galectin-7 modulates the length of the primary cilia and wound repair in polarized kidney epithelial cells.
Data show that high levels of galectin-7 expression in breast cancer cells drastically increased their ability to metastasize to lungs and bones, and were restricted to high-grade breast carcinomas.
Galectin-3 (zeige LGALS3 Proteine) and galectin-7 play a role in corneal epithelial wound healing.
Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype.
The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. Differential and in situ hybridization studies indicate that this lectin is specifically expressed in keratinocytes and found mainly in stratified squamous epithelium. A duplicate copy of this gene (GeneID:653499) is found adjacent to, but on the opposite strand on chromosome 19.
, lectin, galactose binding, soluble 7
, lectin, galactoside-binding, soluble, 7